Scarlett Johansson Stars in Mike Flanagan’s New Exorcist Film

Scarlett Johansson takes the lead in a fresh take on ‘The Exorcist’ under director Mike Flanagan. Universal Pictures holds the franchise rights, acquired in a $400 million deal spanning multiple sequels. Blumhouse Productions and Atomic Monster collaborate on this project, aiming to revive the horror classic after the 2023 entry ‘The Exorcist: Believer’ underperformed at the box office.

Flanagan, known for atmospheric dread in films like ‘Doctor Sleep’ and the Netflix series ‘The Fall of the House of Usher’, brings a radical approach to the material. Johansson, an Oscar nominee for roles in ‘Marriage Story’ and ‘Jojo Rabbit’, selects projects with deliberate care amid her busy schedule. This marks her return to horror since voicing the lead in ‘Ghost in the Shell’ adaptation in 2017.

The original 1973 ‘The Exorcist’ set benchmarks with its possession narrative and groundbreaking effects, grossing over $441 million worldwide on a $12 million budget. Directed by William Friedkin, it featured Linda Blair as the possessed Regan MacNeil and Max von Sydow as Father Merrin. The film’s production involved practical stunts, including a iconic head-spin sequence achieved through custom rigs.

Subsequent entries expanded the lore, with ‘The Exorcist III’ in 1990 introducing psychological twists via William Peter Blatty’s script. The 2023 ‘Believer’ attempted a trilogy start but earned $137 million against a $30 million cost, leading to creative shifts. Universal’s strategy now emphasizes standalone stories within the universe to avoid continuity pitfalls.

Johansson’s casting aligns with her pivot toward prestige genre work, following voice roles in Marvel’s ‘What If…?’ series. Production timelines remain unconfirmed, but Flanagan’s involvement suggests a 2027 release window. The deal secures rights through at least five films, positioning this as a cornerstone revival.

Industry observers note the franchise’s enduring appeal, with home video sales exceeding 20 million units since inception. Johansson’s draw, evidenced by ‘Black Widow’ surpassing $380 million globally, bolsters commercial prospects. Flanagan’s track record, including ‘Oculus’ earning $44 million on $5 million, underscores his fit for elevated horror.

Details on Johansson’s character stay under wraps, fueling speculation of a modern exorcist or familial tie to prior tales. The project’s budget targets mid-range efficiency, around $20-30 million, to maximize returns. Co-financiers Morgan Creek Productions, original rights holders, ensure fidelity to source elements.

As development advances, casting calls seek supporting players versed in ensemble dynamics. Flanagan’s signature slow-burn tension, seen in ‘Midnight Mass’, promises nuanced terror over jump scares. Johansson’s preparation involves script consultations, per production insiders.

Universal’s horror slate, including ‘M3GAN 2.0’, benefits from this momentum. Johansson’s prior genre forays, like ‘Under the Skin’, highlight her versatility in unsettling narratives. The film enters pre-production amid heightened franchise scrutiny.

This iteration sidesteps direct sequels, opting for thematic echoes to the 1973 core. Johansson’s commitment reflects confidence in Flanagan’s vision, distinct from past misfires. Release patterns favor fall slots, aligning with Halloween viability.

Stakeholders anticipate awards buzz for technical achievements, mirroring the original’s 10 Oscar nods. Johansson’s involvement elevates the project’s profile, drawing A-list scrutiny. The collaboration merges her dramatic depth with Flanagan’s genre mastery for a potent mix.

Have something to add? Let us know in the comments below!